Your browser doesn't support javascript.
loading
Relationship between monocyte to high-density lipoprotein cholesterol ratio and the thrombolysis in myocardial infarction risk score in elderly patients with ST-segment elevation myocardial infarction / 中华老年医学杂志
Chinese Journal of Geriatrics ; (12): 1097-1101, 2021.
Article de Zh | WPRIM | ID: wpr-910971
Bibliothèque responsable: WPRO
ABSTRACT
Objective:To investigate the relationship between monocyte to high-density lipoprotein cholesterol ratio(MHR)and the thrombolysis in myocardial infarction(TIMI)risk score in elderly patients with ST elevation myocardial infarction(STEMI).Methods:This was a prospective clinical trial.A total of 152 patients admitted to Tangshan Workers' Hospital were enrolled between January 2015 to February 2018.Of these, 102 STEMI patients undergone primary percutaneous coronary intervention(PCI)were selected as the STEMI group and 50 patients with angiographically normal coronary arteries were selected as the control group.The STEMI patients were divided into two subgroups based on TIMI risk scores.The relationship between MHR and TIMI risk scores in patients with STEMI was analyzed.Logistic regression was used to analyze whether MHR could be used as an independent predictor of acute STEMI and high TIMI scores.Results:The MHR level was significantly higher in the STEMI group than in the control group( P<0.05)and was significantly higher in the high TIMI score subgroup than in the low TIMI score subgroup( P<0.05). In multivariate Logistic regression analysis, MHR was an independent predictor of high TIMI scores in acute STEMI(P<0.05). In correlation analysis, there was a significant positive correlation between MHR and TIMI score in STEMI patients( r=0.396, P<0.01). The ROC curve showed that the area under the curve of MHR was 0.815(95% CI: 0.734-0.896, Z=7.613, P<0.01). When the MHR optimal cut-off value was 2.380, the sensitivity was 55.22% and the specificity was 97.14%. Conclusions:MHR is significantly associated with the TIMI score in patients with STEMI.MHR may be used as a supplementary parameter for assessing the prognosis of STEMI patients.
Mots clés
Texte intégral: 1 Indice: WPRIM Type d'étude: Clinical_trials / Etiology_studies / Prognostic_studies langue: Zh Texte intégral: Chinese Journal of Geriatrics Année: 2021 Type: Article
Texte intégral: 1 Indice: WPRIM Type d'étude: Clinical_trials / Etiology_studies / Prognostic_studies langue: Zh Texte intégral: Chinese Journal of Geriatrics Année: 2021 Type: Article